Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6145926, 7 pages
http://dx.doi.org/10.1155/2016/6145926
Research Article

Cognitive-Enhancing Effect of Aronia melanocarpa Extract against Memory Impairment Induced by Scopolamine in Mice

1Department of Food Science and Engineering, Seowon University, Cheongju 361-742, Republic of Korea
2Department of Medical Biomaterials Engineering, College of Biomedical Science, Kangwon National University, Chuncheon 200-701, Republic of Korea
3Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon 200-701, Republic of Korea

Received 6 January 2016; Revised 25 February 2016; Accepted 20 March 2016

Academic Editor: Michał Tomczyk

Copyright © 2016 Hyeon Yong Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Crapper and U. DeBoni, “Brain aging and Alzheimer's disease,” Canadian Psychiatric Association Journal, vol. 23, no. 4, pp. 229–233, 1978. View at Google Scholar · View at Scopus
  2. S. Sadigh-Eteghad, B. Sabermarouf, A. Majdi, M. Talebi, M. Farhoudi, and J. Mahmoudi, “Amyloid-beta: a crucial factor in Alzheimer's disease,” Medical Principles and Practice, vol. 24, no. 1, pp. 1–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. F. S. Esch, P. S. Keim, E. C. Beattie et al., “Cleavage of amyloid β peptide during constitutive processing of its precursor,” Science, vol. 248, no. 4959, pp. 1122–1124, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. J. J. Palop and L. Mucke, “Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks,” Nature Neuroscience, vol. 13, no. 7, pp. 812–818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. T. Coyle, D. L. Price, and M. R. DeLong, “Alzheimer's disease: a disorder of cortical cholinergic innervation,” Science, vol. 219, no. 4589, pp. 1184–1190, 1983. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Melo, P. Agostinho, and C. R. Oliveira, “Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide,” Neuroscience Research, vol. 45, no. 1, pp. 117–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. B. M. McGleenon, K. B. Dynan, and A. P. Passmore, “Acetylcholinesterase inhibitors in Alzheimer's disease,” British Journal of Clinical Pharmacology, vol. 48, no. 4, pp. 471–480, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. C. G. Ballard, “Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition,” European Neurology, vol. 47, no. 1, pp. 64–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Panja and C. R. Bramham, “BDNF mechanisms in late LTP formation: a synthesis and breakdown,” Neuropharmacology, vol. 76, pp. 664–676, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Saura and J. Valero, “The role of CREB signaling in Alzheimer's disease and other cognitive disorders,” Reviews in the Neurosciences, vol. 22, no. 2, pp. 153–169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Bekinschtein, M. Cammarota, I. Izquierdo, and J. H. Medina, “BDNF and memory formation and storage,” The Neuroscientist, vol. 14, pp. 147–156, 2008. View at Google Scholar
  12. J. Oszmiański and A. Wojdylo, “Aronia melanocarpa phenolics and their antioxidant activity,” European Food Research and Technology, vol. 221, no. 6, pp. 809–813, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. V. Valcheva-Kuzmanova and A. Belcheva, “Current knowledge of Aronia melanocarpa as a medicinal plant,” Folia Medica, vol. 48, no. 2, pp. 11–17, 2006. View at Google Scholar
  14. M. Ciocoiu, L. Badescu, A. Miron, and M. Badescu, “The involvement of a polyphenol-rich extract of black chokeberry in oxidative stress on experimental arterial hypertension,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 912769, 8 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Brzóska, J. Rogalska, M. Galazyn-Sidorczuk, M. Jurczuk, A. Roszczenko, and M. Tomczyk, “Protective effect of Aronia melanocarpa polyphenols against cadmium-induced disorders in bone metabolism: a study in a rat model of lifetime human exposure to this heavy metal,” Chemico-Biological Interactions, vol. 229, pp. 132–146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. J. I. Baum, S. A. Shouse, W. Gilbert, R. L. Prior, and L. R. Howard, “The effect of black chokeberry (Aronia melanocarpa) on the prevention of obesity in C57BL/6J mice,” The FASEB Journal, vol. 27, pp. 861–864, 2013. View at Google Scholar
  17. S. V. Valcheva-Kuzmanova, M. T. Z. Eftimov, R. E. Tashev, I. P. Belcheva, and S. P. Belcheva, “Memory effects of Aronia melanocarpa fruit juice in a passive avoidance test in rats,” Folia Medica, vol. 56, no. 3, pp. 199–203, 2014. View at Google Scholar · View at Scopus
  18. S. Valcheva-Kuzmanova, M. Eftimov, R. Tashev, I. Belcheva, and S. Belcheva, “Effect of Aronia melanocarpa fruit juice on learning and memory in the two-way active avoidance task in rats,” Journal of Biomedical and Clinical Research, vol. 61, pp. 18–23, 2013. View at Google Scholar
  19. J. F. Flood and A. Cherkin, “Scopolamine effects on memory retention in mice: a model of dementia?” Behavioral and Neural Biology, vol. 45, no. 2, pp. 169–184, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. J. O'Keefe and L. Nadel, The Hippocampus as a Cognitive Map, Clarendon Press, Oxford, UK, 1978.
  22. G. L. Ellman, K. D. Courtney, V. Andres Jr., and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961. View at Publisher · View at Google Scholar · View at Scopus
  23. P. R. Lewis and C. C. D. Shute, “Confirmation from choline acetylase analyses of a massive cholinergic innervation to the hippocampus,” The Journal of Physiology, vol. 172, pp. 9–10, 1964. View at Google Scholar
  24. A. Blokland, “Acetylcholine: a neurotransmitter for learning and memory?” Brain Research Reviews, vol. 21, no. 3, pp. 285–300, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. C. R. Bramham and E. Messaoudi, “BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis,” Progress in Neurobiology, vol. 76, no. 2, pp. 99–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Shi, L. Chen, S. Li et al., “Chronic scopolamine-injection-induced cognitive deficit on reward-directed instrumental learning in rat is associated with CREB signaling activity in the cerebral cortex and dorsal hippocampus,” Psychopharmacology, vol. 230, no. 2, pp. 245–260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Kida, “A functional role for CREB as a positive regulator of memory formation and LTP,” Experimental Neurobiology, vol. 21, no. 4, pp. 136–140, 2012. View at Publisher · View at Google Scholar